US Sues Teva Over Generic HIV Drug

Law360, New York (March 18, 2011, 7:06 PM EDT) -- The U.S. government on Tuesday filed suit in New Jersey against a Teva Pharmaceutical Industries Ltd. unit in an effort to block a generic version of HIV drug Prezista, for which the U.S. holds a related patent.

The government filed suit in the U.S. District Court for the District of New Jersey, seeking to bar the U.S. Food and Drug Administration from approving Teva’s abbreviated new drug application for a generic version of Prezista until a patent for a particular method of using the drug expires...
To view the full article, register now.